Form 8-K - Current report:
SEC Accession No. 0001628908-23-000051
Filing Date
2023-03-29
Accepted
2023-03-29 16:01:21
Documents
12
Period of Report
2023-03-28
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 03.29.2023 8-K evh-20230328.htm   iXBRL 8-K 27957
  Complete submission text file 0001628908-23-000051.txt   160584

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20230328.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20230328_lab.xml EX-101.LAB 25850
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20230328_pre.xml EX-101.PRE 13590
6 EXTRACTED XBRL INSTANCE DOCUMENT evh-20230328_htm.xml XML 4453
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 23775127
SIC: 8741 Services-Management Services